These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36879287)

  • 1. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
    Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
    Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience.
    Dankulchai P; Prasartseree T; Sittiwong W; Chansilpa Y; Apiwarodom N; Petsuksiri J; Thephamongkhol K; Treechairusame T; Jitwatcharakomol T; Setakornnukul J; Teyateeti A; Rongthong W; Thaweerat W; Suntornpong N; Veerasarn V; Tuntapakul P; Chareonsiriwat N; Manopetchkasem S
    Clin Oncol (R Coll Radiol); 2024 Nov; 36(11):e456-e467. PubMed ID: 39218741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome.
    Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
    Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
    Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
    Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.
    Faye MD; Petruccelli Araujo M; Wissing MD; Alrabiah K; Gilbert L; Zeng X; Souhami L; Alfieri J
    Curr Oncol; 2023 May; 30(5):4966-4978. PubMed ID: 37232833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
    Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes.
    Mahantshetty U; Gurram L; Bushra S; Ghadi Y; Aravindakshan D; Paul J; Hande V; Pilar A; Chopra S; Ghosh J; Shylasree TS; Popat P; Sable N; Maheswari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):826-834. PubMed ID: 34146636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences.
    Vojtíšek R; Hošek P; Sukovská E; Kovářová P; Baxa J; Ferda J; Fínek J
    Strahlenther Onkol; 2022 Sep; 198(9):783-791. PubMed ID: 35059759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
    Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
    Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.
    Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K
    Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
    Varela Cagetti L; Gonzague-Casabianca L; Zemmour C; Lambaudie E; Houvenaeghel G; Provansal M; Sabatier R; Sabiani L; Blache G; Jauffret C; Ferré M; Mailleux H; Paciencia M; Tallet A
    Gynecol Oncol; 2021 Apr; 161(1):166-172. PubMed ID: 33563488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.